Literature DB >> 19538531

Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience.

Dimitris A Tsitsikas, Heather Oakervee, Jamie D Cavenagh, John Gribben, Samir G Agrawal, Frank M Mattes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19538531     DOI： 10.1111/j.1365-2141.2009.07763.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Viral infections in lung transplant recipients.

Authors:  Pali Dedhiya Shah; John F McDyer
Journal:  Semin Respir Crit Care Med       Date:  2010-03-30       Impact factor: 3.119

Review 2.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

3.  Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.

Authors:  Sachiko Seo; Angela P Campbell; Hu Xie; Jason W Chien; Wendy M Leisenring; Janet A Englund; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-05       Impact factor: 5.742

Review 4.  Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Authors:  Fareed Khawaja; Roy F Chemaly
Journal:  Haematologica       Date:  2019-06-20       Impact factor: 9.941

Review 5.  Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation.

Authors:  Dana J Hawkinson; Michael G Ison
Journal:  Semin Nephrol       Date:  2016-09       Impact factor: 5.299

6.  Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease.

Authors:  Yae-Jean Kim; Katherine A Guthrie; Alpana Waghmare; Edward E Walsh; Ann R Falsey; Jane Kuypers; Anne Cent; Janet A Englund; Michael Boeckh
Journal:  J Infect Dis       Date:  2013-12-23       Impact factor: 5.226

7.  Respiratory syncytial virus pneumonia treated with lower-dose palivizumab in a heart transplant recipient.

Authors:  J L Grodin; K S Wu; E E Kitchell; J Le; J D Mishkin; M H Drazner; D W Markham
Journal:  Case Rep Cardiol       Date:  2011-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.